Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Shares Issued (2019 - 2025)

Viemed Healthcare (VMD) has disclosed Shares Issued for 6 consecutive years, with $71000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued fell 21.98% year-over-year to $71000.0, compared with a TTM value of $1.4 million through Dec 2025, up 41.49%, and an annual FY2025 reading of $1.4 million, up 41.49% over the prior year.
  • Shares Issued was $71000.0 for Q3 2025 at Viemed Healthcare, down from $1.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $1.4 million in Q2 2025 and bottomed at $6000.0 in Q3 2023.
  • Average Shares Issued over 5 years is $276933.3, with a median of $87000.0 recorded in 2022.
  • The sharpest move saw Shares Issued tumbled 97.32% in 2021, then skyrocketed 6361.9% in 2025.
  • Year by year, Shares Issued stood at $47000.0 in 2021, then soared by 317.02% to $196000.0 in 2022, then plummeted by 64.8% to $69000.0 in 2023, then surged by 771.01% to $601000.0 in 2024, then plummeted by 88.19% to $71000.0 in 2025.
  • Business Quant data shows Shares Issued for VMD at $71000.0 in Q3 2025, $1.4 million in Q2 2025, and $11000.0 in Q1 2025.